Low-dose endotoxin potentiates capsaicin-induced pain in man: Evidence for a pain neuroimmune connection

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 3-11

  Hutchinson, Mark R ^a   Buijs, Mara ^b   Tuke, Jonathan ^a   Kwok, Yuen Hei ^a   Gentgall, Melanie ^c   Williams, Desmond ^d   Rolan, Paul ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b LEIDEN UNIVERSITY   (Netherlands)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Capsaicin; Chronic pain; Endotoxin; TLR4

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; ENDOTOXIN; TOLL LIKE RECEPTOR 4;

ADULT; ALLODYNIA; ARTICLE; BRAIN DEPTH STIMULATION; CHRONIC PAIN; ENZYME ACTIVATION; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; IMMUNOMODULATION; MALE; NEUROPATHIC PAIN; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; CAPSAICIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTOXINS; HUMANS; HYPERALGESIA; MALE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; TOLL-LIKE RECEPTOR 4;

EID: 84876821683     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.03.002     Document Type: Article

References (53)

1. Andresen T., Staahl C., Oksche A., Mansikka H., Arendt-Nielsen L., Drewes A.M. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain. Br. J. Pharmacol. 2011, 164:934-945.
2. Aykanat V., Gentgall M., Briggs N., Williams D., Yap S., Rolan P. Intradermal capsaicin as a neuropathic pain model in patients with unilateral sciatica. Br. J. Clin. Pharmacol. 2012, 73:37-45.
3. Bates, D., Maechler, M., Bolker, B., 2012. lme4: linear mixed-effects models using S4 classes.
4. Benson S., Kattoor J., Wegner A., Hammes F., Reidick D., Grigoleit J.-S., Engler H., Oberbeck R., Schedlowski M., Elsenbruch S. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012, 153:794-799.
5. Chabriat H., Danchot J., Michel P., Joire J.E., Henry P. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 1999, 39:335-338.
6. Chung M.K., Lee J., Duraes G., Ro J.Y. Lipopolysaccharide-induced pulpitis up-regulates TRPV1 in trigeminal ganglia. J. Dent. Res. 2011, 90:1103-1107.
7. Diogenes A., Ferraz C.C.R., Akopian A.N., Henry M.A., Hargreaves K.M. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J. Dent. Res. 2011, 90:759-764.
8. Ferraz C.C.R., Henry M.A., Hargreaves K.M., Diogenes A. Lipopolysaccharide from Porphyromonas gingivalis sensitizes capsaicin-sensitive nociceptors. J. Endod. 2011, 37:45-48.
9. Franco-Cereceda A., Henke H., Lundberg J.M., Petermann J.B., Hökfelt T., Fischer J.A. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides 1987, 8:399-410.
10. Gazerani P., Andersen O.K., Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 2005, 118:155-163.
11. Gazerani P., Staahl C., Drewes A.M., Arendt-Nielsen L. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization. Pain 2006, 122:315-325.
12. Gottrup H., Juhl G., Kristensen A.D., Lai R., Chizh B.A., Brown J., Bach F.W., Jensen T.S. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 2004, 101:1400-1408.
13. Gourine A.V., Rudolph K., Korsak A.S., Kubatko J., Tesfaigzi J., Kozak W., Kluger M.J. Role of capsaicin-sensitive afferents in fever and cytokine responses during systemic and local inflammation in rats. Neuroimmunomodulation 2001, 9:13-22.
14. Grace P.M., Rolan P.E., Hutchinson M.R. Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Brain Behav. Immun. 2011, 25:1322-1332.
15. Gustafsson H., Akesson J., Lau C.L., Williams D., Miller L., Yap S., Rolan P. A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers. Br. J. Clin. Pharmacol. 2009, 68:511-517.
16. Herbert M.K., Hering S. Tumor necrosis factor-alpha prevents interleukin-1 beta from augmenting capsaicin-induced vasodilatation in the rat skin. Eur. J. Pharmacol. 1995, 286:273-279.
17. Herbert M.K., Holzer P. Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br. J. Pharmacol. 1994, 111:681-686.
18. Herbert M.K., Holzer P. Nitric oxide mediates the amplification by interleukin-1 beta of neurogenic vasodilatation in the rat skin. Eur. J. Pharmacol. 1994, 260:89-93.
19. Hua X.-Y., Chen P., Fox A., Myers R.R. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha. J. Neurosci. 1996, 16:4742-4748.
20. Hutchinson M.R., Ramos K.M., Loram L.C., Wieseler J., Sholar P.W., Kearney J.J., Lewis M.T., Crysdale N.Y., Zhang Y., Harrison J.A., Maier S.F., Rice K.C., Watkins L.R. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience 2009, 164:1821-1832.
21. Kemper R.H., Spoelstra M.B., Meijler W.J., Ter Horst G.J. Lipopolysaccharide-induced hyperalgesia of intracranial capsaicin sensitive afferents in conscious rats. Pain 1998, 78:181-190.
22. Kett D.H., Breitmeyer J.B., Ang R., Royal M.A. A randomized study of the efficacy and safety of intravenous acetaminophen vs. intravenous placebo for the treatment of fever. Clin. Pharmacol. Ther. 2011, 90:32-39.
23. Kraft B., Frickey N.A., Kaufmann R.M., Reif M., Frey R., Gustorff B., Kress H.G. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology 2008, 109:101-110.
24. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
25. Landry R.P., Jacobs V.L., Romero-Sandoval E.A., DeLeo J.A. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp. Neurol. 2012, 234:340-350.
26. Liu M., Max M.B., Robinovitz E., Gracely R.H., Bennett G.J. The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction. J. Pain Symptom Manage. 1998, 16:10-20.
27. Liu L., Yang T.M., Liedtke W., Simon S.A. Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J. Neurophysiol. 2006, 95:1478-1490.
28. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10:23-36.
29. Musumeci G., Grasselli G., Rossi S., De Chiara V., Musella A., Motta C., Studer V., Bernardi G., Haji N., Sepman H., Fresegna D., Maccarrone M., Mandolesi G., Centonze D. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiol. Dis. 2011, 43:669-677.
30. Nicol G.D., Lopshire J.C., Pafford C.M. Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J. Neurosci. 1997, 17:975-982.
31. Nicotra L., Loram L.C., Watkins L.R., Hutchinson M.R. Toll-like receptors in chronic pain. Exp. Neurol. 2012, 234:316-329.
32. Nightingale S. The neuropathic pain market. Nat. Rev. Drug Discov. 2012, 11:101-102.
33. Obreja O., Schmelz M., Poole S., Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 2002, 96:57-62.
34. Oprée A., Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. 2000, 20:6289-6293.
35. Pöyhiä R., Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin. J. Pain 2006, 22:32-36.
36. Ramos K.M., Lewis M.T., Morgan K.N., Crysdale N.Y., Kroll J.L., Taylor F.R., Harrison J.A., Sloane E.M., Maier S.F., Watkins L.R. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 2010, 169:1888-1900.
37. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
38. Rohrer M., Berger M.M., Pittet Y.K., Delodder F., Tappy L., Feihl F., Chioléro R.L. Metabolic and physiologic effects of an endotoxin challenge in healthy obese subjects. Clin. Physiol. Funct. Imaging 2011, 31:371-375.
39. Rolan P., Gibbons J.A., He L., Chang E., Jones D., Gross M.I., Davidson J.B., Sanftner L.M., Johnson K.W. Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. Br. J. Clin. Pharmacol. 2008, 66:792-801.
40. Russell F.A., Fernandes E.S., Courade J.-P., Keeble J.E., Brain S.D. Tumour necrosis factor alpha mediates transient receptor potential vanilloid 1-dependent bilateral thermal hyperalgesia with distinct peripheral roles of interleukin-1beta, protein kinase C and cyclooxygenase-2 signalling. Pain 2009, 142:264-274.
41. Sang C.N., Gracely R.H., Max M.B., Bennett G.J. Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology 1996, 85:491-496.
42. Shanley L., Lear M., Davidson S., Ross R., MacKenzie A. Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones. J. Neuroinflammation 2011, 8:10.
43. Stewart W.F., Ricci J.A., Chee E., Morganstein D., Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003, 290:2443-2454.
44. Sumracki N.M., Hutchinson M.R., Gentgall M., Briggs N., Williams D.B., Rolan P. The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica. PLoS ONE 2012, 7:e38525.
45. Wadachi R., Hargreaves K.M. Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J. Dent. Res. 2006, 85:49-53.
46. Wallace M.S., Schulteis G. Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study. Clin. J. Pain 2008, 24:544-549.
47. Wallace M.S., Quessy S., Schulteis G. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model. Pharmacol. Biochem. Behav. 2004, 78:349-355.
48. Wallace M., Schulteis G., Atkinson J.H., Wolfson T., Lazzaretto D., Bentley H., Gouaux B., Abramson I. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 2007, 107:785-796.
49. Wang H., Bolognese J., Calder N., Baxendale J., Kehler A., Cummings C., Connell J., Herman G. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. J. Pain 2008, 9:1088-1095.
50. Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med. 2005, 257:139-155.
51. Watkins L.R., Hutchinson M.R., Johnson K.W. Commentary on Landry et al. Propentofylline, a CNS glial modulator, does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp. Neurol. 2012, 234:351-353.
52. Zhang R.X., Li A., Liu B., Wang L., Ren K., Zhang H., Berman B.M., Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239.
53. Zhang R.X., Liu B., Li A., Wang L., Ren K., Qiao J.T., Berman B.M., Lao L. Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. Neuroscience 2008, 154:1533-1538.